Background and Objectives. The aim of this study was the development of a f
ast and reliable polymerase chain reaction (PCR) assay which quantifies the
proportion of human cells in immunodeficient chimeric mice, for Example tr
ansplanted with human hematopoietic stem cells.
Design and Methods. We developed a TaqMan chemistry-based, real-time duplex
PCR assay to quantify human and murine DNA in a single-tube reaction in pa
rallel (HUmu PCR). Two independent sets of primers and exonuclease probes,
located in the tumor necrosis factor-alpha gene of both species, were selec
ted to amplify specifically human and murine genomic DNA. Serial dilutions
of defined numbers of human cells in mouse cells served to construct calibr
ation curves. The test was applied to NOD/SCID mice transplanted with CD34(
+) cells isolated from human cord blood and compared to FACS analysis.
Results. Analysis of DNA from human cells diluted stepwise into a fixed num
ber of murine cells - and vice versa - led to calibration curves with good
correlation for human and murine cells (r(2)>0.99) with a detection limit o
f 2% human cells, Results obtained with the HUmu PCR paralleled those of FA
CS analysis. However, in contrast to FACS analysis, which requires fresh si
ngle cell suspensions, the HUmu PCR can be carried out on already stored sa
mples, even from solid organs and, moreover, the quantity of material requi
red for analysis is very low.
Interpretation and Conclusions. The HUmu PCR presented here is the first re
al-time PCR assay for simultaneous quantification of human and murine cells
. It is extremely fast, accurate and is an interesting alternative method f
or quantifying the proportion of human DNA in organs of chimeric mice. (C)
2001, Ferrata Storti Foundation.